Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Previously Treated Metastatic Adenocarcinoma of the Pancreas”

45 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 45 results

Testing effectiveness (Phase 2)Study completedNCT00397787
What this trial is testing

Sunitinib in Treating Patients With Metastatic Pancreatic Cancer That Progressed After First-Line Therapy With Gemcitabine

Who this might be right for
Acinar Cell Adenocarcinoma of the PancreasDuct Cell Adenocarcinoma of the PancreasRecurrent Pancreatic Cancer+1 more
National Cancer Institute (NCI) 64
Large-scale testing (Phase 3)Study completedNCT00099294
What this trial is testing

Study of the Efficacy and Safety of Glufosfamide Compared With Best Supportive Care in Metastatic Pancreatic Cancer

Who this might be right for
Pancreatic Cancer
Threshold Pharmaceuticals 300
Testing effectiveness (Phase 2)Study completedNCT03190265
What this trial is testing

Study of CRS-207, Nivolumab, and Ipilimumab With or Without GVAX Pancreas Vaccine (With Cy) in Patients With Pancreatic Cancer

Who this might be right for
Pancreatic Cancer
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins 61
Testing effectiveness (Phase 2)Ended earlyNCT02202785
What this trial is testing

MLN0264 in Patients With Pancreatic Cancer

Who this might be right for
Pancreatic Adenocarcinoma
Millennium Pharmaceuticals, Inc. 43
Testing effectiveness (Phase 2)Study completedNCT00126633
What this trial is testing

Gemcitabine, Cisplatin, and Bevacizumab in Treating Patients With Metastatic Pancreatic Cancer

Who this might be right for
Pancreatic Cancer
University of California, San Francisco 53
Early research (Phase 1)Looking for participantsNCT06983743
What this trial is testing

ERAS-0015 in Patients With Advanced or Metastatic Solid Tumors

Who this might be right for
Metastatic Solid Tumors
Erasca, Inc. 600
Testing effectiveness (Phase 2)Study completedNCT05014776
What this trial is testing

Study of CRS-207, Pembrolizumab, Ipilimumab, and Tadalafil in Metastatic Pancreatic Cancer

Who this might be right for
Pancreatic Cancer
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins 17
Testing effectiveness (Phase 2)Study completedNCT02551991
What this trial is testing

Study of Nanoliposomal Irinotecan (Nal-IRI)-Containing Regimens Versus Nab-paclitaxel Plus Gemcitabine in Patients With Previously Untreated, Metastatic Pancreatic Adenocarcinoma

Who this might be right for
Pancreatic Cancer
Ipsen 56
Testing effectiveness (Phase 2)Study completedNCT00923299
What this trial is testing

Cetuximab and Trastuzumab in Treating Patients With Metastatic Pancreatic Cancer That Progressed After Previous Treatment With Gemcitabine

Who this might be right for
Pancreatic Cancer
Institut du Cancer de Montpellier - Val d'Aurelle 33
Testing effectiveness (Phase 2)Study completedNCT03410030
What this trial is testing

Trial of Ascorbic Acid (AA) + Nanoparticle Paclitaxel Protein Bound + Cisplatin + Gemcitabine (AA NABPLAGEM)

Who this might be right for
Pancreatic CancerPancreas CancerPancreatic Adenocarcinoma Resectable+2 more
HonorHealth Research Institute 17
Early research (Phase 1)Study completedNCT04787991
What this trial is testing

Exploratory Platform Trial to Evaluate Immunotherapy Combinations With Chemotherapy for the Treatment of Patients With Previously Untreated Metastatic Pancreatic Adenocarcinoma

Who this might be right for
Metastatic Pancreatic Adenocarcinoma
Cancer Insight, LLC 45
Testing effectiveness (Phase 2)Study completedNCT00735917
What this trial is testing

Saracatinib in Treating Patients With Previously Treated Metastatic Pancreatic Cancer

Who this might be right for
Adenocarcinoma of the PancreasRecurrent Pancreatic CancerStage IV Pancreatic Cancer
National Cancer Institute (NCI) 19
Testing effectiveness (Phase 2)Study completedNCT02194829
What this trial is testing

Paclitaxel Albumin-Stabilized Nanoparticle Formulation and Gemcitabine Hydrochloride With or Without WEE1 Inhibitor AZD1775 in Treating Patients With Previously Untreated Pancreatic Cancer That Is Metastatic or Cannot Be Removed by Surgery

Who this might be right for
Metastatic Pancreatic AdenocarcinomaStage III Pancreatic Cancer AJCC v6 and v7Stage IV Pancreatic Cancer AJCC v6 and v7+1 more
National Cancer Institute (NCI) 8
Testing effectiveness (Phase 2)Ended earlyNCT00066677
What this trial is testing

Bevacizumab With or Without Docetaxel in Treating Patients With Previously Treated Metastatic Pancreatic Cancer

Who this might be right for
Pancreatic Cancer
Fox Chase Cancer Center 32
Testing effectiveness (Phase 2)Study completedNCT02004262
What this trial is testing

Safety and Efficacy of Combination Listeria/GVAX Pancreas Vaccine in the Pancreatic Cancer Setting

Who this might be right for
2nd-line, 3rd-line and Greater Metastatic Pancreatic Cancer
Aduro Biotech, Inc. 303
Testing effectiveness (Phase 2)WithdrawnNCT01473303
What this trial is testing

Combination Chemotherapy With or Without Ganitumab in Treating Patients With Previously Untreated Metastatic Pancreatic Cancer

Who this might be right for
Pancreatic Cancer
Alliance for Clinical Trials in Oncology
Testing effectiveness (Phase 2)Ended earlyNCT02109445
What this trial is testing

Study Of PF-03084014 In Combination With Gemcitabine And Nab-Paclitaxel In Patients With Metastatic Pancreatic Adenocarcinoma Not Previously Treated With Anticancer Therapies

Who this might be right for
Metastatic Cancer Pancreas
Pfizer 3
Large-scale testing (Phase 3)Study completedNCT04083235
What this trial is testing

Assess the Effectiveness and Safety of Irinotecan Liposome Injection, 5-fluorouracil/Leucovorin Plus Oxaliplatin in Patients Not Previously Treated for Metastatic Pancreatic Cancer, Compared to Nab-paclitaxel+Gemcitabine Treatment

Who this might be right for
Metastatic Adenocarcinoma of the Pancreas
Ipsen 770
Testing effectiveness (Phase 2)Study completedNCT02243371
What this trial is testing

GVAX Pancreas Vaccine (With CY) and CRS-207 With or Without Nivolumab

Who this might be right for
Previously Treated Metastatic Adenocarcinoma of the Pancreas
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins 93
Testing effectiveness (Phase 2)Active Not RecruitingNCT01585805
What this trial is testing

Gemcitabine Hydrochloride and Cisplatin With or Without Veliparib or Veliparib Alone in Treating Patients With Locally Advanced or Metastatic Pancreatic Cancer

Who this might be right for
Locally Advanced Pancreatic AdenocarcinomaMetastatic Pancreatic AdenocarcinomaStage III Pancreatic Cancer AJCC v8+1 more
National Cancer Institute (NCI) 83
Next Page